Role of personalized medication training in improving efficacy and adherence to a topical therapy in psoriatic patients

J Dermatolog Treat. 2017 Dec;28(8):722-725. doi: 10.1080/09546634.2017.1328100. Epub 2017 May 29.

Abstract

Background: Poor adherence to topical therapy, defined as the degree to which patients use medication as prescribed by their healthcare provider, represents a frequent cause of poor treatment outcomes.

Objective: To evaluate the impact of individualized medication training on efficacy, adherence and patient satisfaction to 4 weeks of a topical therapy in psoriasis.

Methods: All enrolled psoriatic patients were given a prescription for calcipotriol/betamethasone dipropionate gel once daily and were randomly assigned to one of the two following groups with a 1:1 allocation ratio. Patients in group 1 and group 2 underwent an initial visit, including the physical examination and provision of information by the dermatologist. Patients in group 2 also received an additional 20 min of individualized medication training. Efficacy, adherence and patient satisfaction were evaluated after 4 weeks of treatment.

Results: We enrolled 104 consecutive patients with psoriasis: patients in group 2, who were trained, had a significant improvement at week 4 in BSA, PASI, dPGA and higher PPQ score, and were more adherent compared to those in group 1 who were not trained.

Conclusion: Individualized medication training on the correct application of a topical therapy from a healthcare professional may improve patients' adherence, treatment tolerability and clinical outcomes.

Keywords: Psoriasis; adherence; topical therapy.

MeSH terms

  • Administration, Topical
  • Adult
  • Aged
  • Aged, 80 and over
  • Betamethasone / analogs & derivatives
  • Betamethasone / therapeutic use
  • Calcitriol / analogs & derivatives
  • Calcitriol / therapeutic use
  • Dermatologic Agents / therapeutic use*
  • Drug Administration Schedule
  • Drug Combinations
  • Female
  • Humans
  • Linear Models
  • Male
  • Middle Aged
  • Patient Compliance
  • Patient Education as Topic*
  • Patient Satisfaction
  • Psoriasis / drug therapy*
  • Psoriasis / pathology
  • Psoriasis / psychology
  • Quality of Life
  • Severity of Illness Index
  • Surveys and Questionnaires
  • Young Adult

Substances

  • Dermatologic Agents
  • Drug Combinations
  • calcipotriene
  • betamethasone-17,21-dipropionate
  • Betamethasone
  • Calcitriol